References
- Yadav J. S., Wholey M. H., Kuntz R. E., Fayad P., Katzen B. T., Mishkel G. J., et al. Protected carotid‐artery stenting versus endarterectomy in high‐risk patients. N Engl J Med 2004; 351: 1493–501
- Hofmann R., Kypta A., Steinwender C., Kerschner K., Grund M., Leisch F. Coronary angiography in patients undergoing carotid artery stenting reveals a high incidence of significant coronary artery disease. Heart 2005; 91: 1438–41
- Campeau L. Grading of angina pectoris. Circulation 1976; 54: 522–3
- North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high‐grade carotid stenosis. N Engl J Med 1991; 325: 445–53
- Emond M., Mock M. B., Davis K. B., Fisher L. D., Holmes D. R., Jr., Chaitman B. R., et al. Long‐term survival of medically treated patients in the Coronary Artery Surgery Study (CASS) Registry. Circulation 1994; 90: 2645–57
- Wholey M. H., Wholey M., Mathias K., Roubin G. S., Diethrich E. B., Henry M., et al. Global experience in cervical carotid artery stent placement. Cathet Cardiovasc Interv 2000; 50: 160–7
- Brott T., Adams H. P., Olinger C. P., Marler J. R., Barsan W. G., Biller J., et al. Measurement of acute cerebral infarction: a clinical examination scale. Stroke 1989; 20: 864–70
- Schühlen H., Kastrati A., Dirschinger J., Hausleiter J., Elezi S., Wehinger A., et al. Intracoronary stenting and risk for major adverse cardiac events during the first month. Circulation 1998; 98: 104–11
- Viles‐Gonzalez J. F., Fuster V., Badimon J. J. Atherothrombosis: A widespread disease with unpredictable and life‐threatening consequences. Eur Heart J 2004; 25: 1197–207
- Lombardo A., Biasucci L. M., Lanza G. A., Coli S., Silvestri P., Cianflone D., et al. Inflammation as a possible link between coronary and carotid plaque instability. Circulation 2004; 109: 3158–63
- Fuster V. Epidemic of cardiovascular disease and stroke: the three main challenges. Circulation 1999; 99: 1132–7
- Dennis M. S., Burn J. P., Sandercock P. A., Bamford J. M., Wade D. T., Warlow C. P. Long‐term survival after first‐ever stroke: the Oxfordshire Community Stroke Project. Stroke 1993; 24: 796–800
- Hankey G. J., Jamrozik K., Broadhurst R. J., Forbes S., Burvill P. W., Anderson C. S., et al. Five‐year survival after first‐ever stroke and related prognostic factors in the Perth Community Stroke Study. Stroke 2000; 31: 2080–6
- Hartmann A., Rundek T., Mast H., Paik M. C., Boden‐Albala B., Mohr J. P., et al. Mortality and causes of death after first ischemic stroke: the Northern Manhattan Stroke Study. Neurology 2001; 57: 2000–5
- Katritsis D. G., Karvouni E., Ioannidis J. P. Meta‐analysis comparing drug‐eluting stents with bare metal stents. Am J Cardiol 2005; 95: 640–3
- Dakik H. A., Kleiman N. S., Farmer J. A., He Z. X., Wendt J. A., Pratt C. M., et al. Intensive medical therapy versus coronary angioplasty for suppression of myocardial ischemia in survivors of acute myocardial infarction: a prospective, randomized pilot study Circulation. 1998; 98: 2017–23
- Hambrecht R., Walther C., Mobius‐Winkler S., Gielen S., Linke A., Conradi K., et al. Percutaneous coronary angioplasty compared with exercise training in patients with stable coronary artery disease: a randomized trial. Circulation 2004; 109: 1371–8
- Zeymer U., Uebis R., Vogt A., Glunz H. G., Vohringer H. F., Harmjanz D., , ALKK‐Study Group, et al. Randomized comparison of percutaneous transluminal coronary angioplasty and medical therapy in stable survivors of acute myocardial infarction with single vessel disease: a study of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausaerzte. Circulation 2003; 108: 1324–8
- Hueb W., Soares P. R., Gersh B. J., Cesar L. A., Luz P. L., Puig L. B., et al. The medicine, angioplasty, or surgery study (MASS‐II): a randomized, controlled clinical trial of three therapeutic strategies for multivessel coronary artery disease: one‐year results. J Am Coll Cardiol 2004; 43: 1743–51
- Henderson R. A., Pocock S. J., Clayton T. C., Knight R., Fox K. A., Julian D. G., , Second Randomized Intervention Treatment of Angina (RITA‐2) Trial Participants, et al. Seven‐year outcome in the RITA‐2 trial: coronary angioplasty versus medical therapy. J Am Coll Cardiol 2003; 42: 1161–70
- Folland E. D., Hartigan P. M., Parisi A. F. Percutaneous transluminal coronary angioplasty versus medical therapy for stable angina pectoris: outcomes for patients with double‐vessel versus single‐vessel coronary artery disease in a Veterans Affairs Cooperative randomized trial. Veterans Affairs ACME InvestigatorS. J Am Coll Cardiol 1997; 29: 1505–11
- Pitt B., Waters D., Brown W. V., van Boven A. J., Schwartz L., Title L. M., et al. Aggressive lipid‐lowering therapy compared with angioplasty in stable coronary artery disease. Atorvastatin versus Revascularization Treatment Investigators. N Engl J Med 1999; 341: 70–6
- Rihal C. S., Raco D. L., Gersh B. J., Yusuf S. Indications for coronary artery bypass surgery and percutaneous coronary intervention in chronic stable angina: review of the evidence and methodological considerations. Circulation 2003; 108: 2439–45
- Corti R., Fuster V., Badimon J. J. Pathogenetic concepts of acute coronary syndromes. J Am Coll Cardiol 2002; 90: 7S–14S
- Van der Wal A. C., Becker A. E., Van de Loos C. M., Das P. K. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation 1994; 89: 36–44
- Babapulle M. N., Joseph L., Belisle P., Brophy J. M., Eisenberg M. J. A hierarchical Bayesian meta‐analysis of randomised clinical trials of drug‐eluting stents. Lancet 2004; 364: 583–91